01 مايو #CDK4 #Mutation #Next-generation #Ovarian Cancer #Palbociclib #RB1 #sequencing #TP53 Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer by Dr. Fadi Farhat 0
